日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Risk factors for thyroid nodules in a health examination population: a cross-sectional study and development of a simplified predictive model

健康体检人群甲状腺结节的危险因素:一项横断面研究及简化预测模型的建立

Yu, Hangtian; Cao, Jingle; Han, Jing; Li, Yang; Li, Wenyu; Li, Zihan; Zhang, Jinjia; Zhang, YaLi

Association between blood eosinophil levels and prognosis in critically ill patients with different heart failure phenotypes

血液嗜酸性粒细胞水平与不同心力衰竭表型危重患者预后的关系

Guan, Chengjian; Wang, Keke; Gong, Angwei; Zhao, Yan; Yu, Hangtian; Zhang, Shuaidan; Jin, Sheng; Wang, Lixuan; Xiao, Bing

Piezo1 activation protects against sepsis-induced myocardial dysfunction in a pilot study.

初步研究表明,Piezo1 激活可防止脓毒症引起的心肌功能障碍

Gong Angwei, Dai Jing, Zhao Yan, Hu Haijuan, Guan Chengjian, Yu Hangtian, Wang Keke, Jin Sheng, Wu Yuming, Xiao Bing

Unsupervised learning-derived phenotypes for personalized fluid management in critically ill patients with heart failure: A multicenter study

基于无监督学习的表型在危重心力衰竭患者个体化液体管理中的应用:一项多中心研究

Guan, Chengjian; Gong, Angwei; Zhao, Yan; Yu, Hangtian; Zhang, Shuaidan; Xie, Zhiyi; Jin, Yehui; Yang, Xiuchun; Lu, Jingchao; Xiao, Bing

Sensory nerve EP4 facilitates heterotopic ossification by regulating angiogenesis-coupled bone formation

感觉神经 EP4 通过调节血管生成偶联骨形成促进异位骨化

Rongmin Lin, Hancheng Lin, Chencheng Zhu, Jieming Zeng, Jiahui Hou, Ting Xu, Yihui Tan, Xuyou Zhou, Yuan Ma, Mankai Yang, Kuanhai Wei, Bin Yu, Hangtian Wu, Zhuang Cui

Causal association between systemic lupus erythematosus and the risk of migraine: A Mendelian randomization study

系统性红斑狼疮与偏头痛风险之间的因果关系:一项孟德尔随机化研究

Ren, Meixuan; Yu, Hangtian; Xiao, Bing; Zhao, Yan; Yan, Jiewei; Liu, Jianghong

Genetically predicted hypothyroidism, thyroid hormone treatment, and the risk of cardiovascular diseases: a mendelian randomization study

基因预测的甲状腺功能减退症、甲状腺激素治疗与心血管疾病风险:一项孟德尔随机化研究

Zhang, Shuaidan; Yu, Hangtian; Zhao, Yan; Gong, Angwei; Guan, Chengjian; Chen, Shuchen; Xiao, Bing; Lu, Jingchao

High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors

高通量筛选确定已确定的药物为 SARS-CoV-2 PLpro 抑制剂

Yao Zhao #, Xiaoyu Du #, Yinkai Duan #, Xiaoyan Pan #, Yifang Sun #, Tian You #, Lin Han #, Zhenming Jin, Weijuan Shang, Jing Yu, Hangtian Guo, Qianying Liu, Yan Wu, Chao Peng, Jun Wang, Chenghao Zhu, Xiuna Yang, Kailin Yang, Ying Lei, Luke W Guddat, Wenqing Xu, Gengfu Xiao, Lei Sun, Leike Zhang, Zi